Evidence map›Paper›PMID 25574827›Full record

ArticleAmerican journal of human genetics2015

HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy.

Hanna M Ollila, Jean-Marie Ravel, Fang Han, Juliette Faraco, Ling Lin, Xiuwen Zheng, Giuseppe Plazzi, Yves Dauvilliers, Fabio Pizza, Seung-Chul Hong and 25 more

Erratum issuedAbstract read
In one paragraph

Article in American journal of human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. The immunopathogenesis of narcolepsy type 1.Nature reviews. Immunology · 2024
    Review
  8. A series of 7 cases of patients with narcolepsy with hypocretin deficiency without the HLA DQB1*06:02 allele.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
    Lavault, Sophie [removed]; Arnulf, Isabelle [added]
5 · Who and what money

Authors and funding

35 authors.

Hanna M OllilaStanford University Center for Sleep Sciences, Palo Alto, CA 94304, USA.
Jean-Marie RavelStanford University Center for Sleep Sciences, Palo Alto, CA 94304, USA.
Fang HanDepartment of Pulmonary Medicine, Peking University People's Hospital, 100044 Beijing, China.
Juliette FaracoStanford University Center for Sleep Sciences, Palo Alto, CA 94304, USA.
Ling LinStanford University Center for Sleep Sciences, Palo Alto, CA 94304, USA.
Xiuwen ZhengDepartment of Biostatistics, University of Washington, PO box 357232, Seattle, WA 98195, USA.
Giuseppe PlazziDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Via Ugo Foscolo 7, 40123 Bologna, Italy; IRCCS Institute of Neurological Sciences, 40139 Bologna, Italy.
Yves DauvilliersINSERM U1061, Reference Center for Narcolepsy, Sleep-Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, Centre Hospitalier Régional Universitaire Montpellier, 34090 Montpellier, France.
Fabio PizzaDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Via Ugo Foscolo 7, 40123 Bologna, Italy; IRCCS Institute of Neurological Sciences, 40139 Bologna, Italy.
Seung-Chul HongDepartment of Psychiatry, St. Vincent's Hospital, The Catholic University of Korea, 442-723 Suwon, Korea.
Poul JennumDanish Center for Sleep Medicine, Department of Clinical Neurophysiology, University of Copenhagen, Glostrup Hospital, 2600 Glostrup, Denmark.
Stine KnudsenNorwegian Resource Center for ADHD, TS, and Narcolepsy, Oslo University Hospital, 0450 Ullevål, Norway.
Birgitte R KornumDanish Center for Sleep Medicine, Department of Clinical Neurophysiology, University of Copenhagen, Glostrup Hospital, 2600 Glostrup, Denmark; Molecular Sleep Laboratory, Department of Diagnostics, Glostrup Hospital, 2600 Glostrup, Denmark.
Xiao Song DongDepartment of Pulmonary Medicine, Peking University People's Hospital, 100044 Beijing, China.
Han YanDepartment of Pulmonary Medicine, Peking University People's Hospital, 100044 Beijing, China.
Heeseung HongStanford University Center for Sleep Sciences, Palo Alto, CA 94304, USA.
Cristin CoquillardDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94304, USA.
Joshua MahliosStanford University Center for Sleep Sciences, Palo Alto, CA 94304, USA.
Otto JolankiStanford University Center for Sleep Sciences, Palo Alto, CA 94304, USA.
Mali EinenStanford University Center for Sleep Sciences, Palo Alto, CA 94304, USA.
Isabelle Arnulf
Sophie LavaultCentre National de Réferénce Narcolepsie et Hypersomnie, 75019 Paris, France.
Birgit HöglDepartment of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Birgit FrauscherDepartment of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Catherine CroweMater Private Hospital, Dublin 7, Ireland.
Markku PartinenHelsinki Sleep Clinic, Vitalmed Research Centre, 00420 Helsinki, Finland; Department of Clinical Neurosciences, University of Helsinki, 00100 Helsinki, Finland.
Yu Shu HuangChang Gung Memorial Hospital and University, Taipei 10591, Taiwan.
Patrice BourginDepartment of Sleep Medicine, Strasbourg University Hospital, Strasbourg University, 67084 Strasbourg, France.
Outi VaaralaInstitute of Clinical Medicine, University of Helsinki, 00100 Helsinki, Finland.
Alex DésautelsCenter for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur and Department of Neurosciences, University of Montreal, Montreal, QC H3T 1J4, Canada.
Jacques MontplaisirCenter for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur and Department of Psychiatry, University of Montreal, Montreal QC H3T 1J4, Canada.
Steven J MackChildren's Hospital Oakland Research Institute, 5700 Martin Luther King Junior Way, Oakland, CA 94609-1673, USA.
Michael MindrinosStanford Genome Technology Center, Stanford University, Palo Alto, CA 94304, USA.
Marcelo Fernandez-VinaDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94304, USA.
Emmanuel MignotStanford University Center for Sleep Sciences, Palo Alto, CA 94304, USA. Electronic address: mignot@stanford.edu.

Funding

SPECTRUM OF NARCOLEPSY AND ITS SYMPTOMSP50NS023724 · NINDS · STANFORD UNIVERSITY · PI MIGNOT, EMMANUEL J · 1986 to 2016
$18.9M
CENTER FOR NARCOLEPSY AND RELATED DISORDERSP01NS023724 · NINDS · STANFORD UNIVERSITY · PI DEMENT, WILLIAM C · 1987 to 1988
–
NINDS NIH HHS NS23724NINDS NIH HHS P50 NS023724Wellcome Trust
6 · The paper itself

Abstract

Type 1 narcolepsy, a disorder caused by a lack of hypocretin (orexin), is so strongly associated with human leukocyte antigen (HLA) class II HLA-DQA1(∗)01:02-DQB1(∗)06:02 (DQ0602) that very few non-DQ0602 cases have been reported. A known triggering factor for narcolepsy is pandemic 2009 influenza H1N1, suggesting autoimmunity triggered by upper-airway infections. Additional effects of other HLA-DQ alleles have been reported consistently across multiple ethnic groups. Using over 3,000 case and 10,000 control individuals of European and Chinese background, we examined the effects of other HLA loci. After careful matching of HLA-DR and HLA-DQ in case and control individuals, we found strong protective effects of HLA-DPA1(∗)01:03-DPB1(∗)04:02 (DP0402; odds ratio [OR] = 0.51 [0.38-0.67], p = 1.01 × 10(-6)) and HLA-DPA1(∗)01:03-DPB1(∗)04:01 (DP0401; OR = 0.61 [0.47-0.80], p = 2.07 × 10(-4)) and predisposing effects of HLA-DPB1(∗)05:01 in Asians (OR = 1.76 [1.34-2.31], p = 4.71 × 10(-05)). Similar effects were found by conditional analysis controlling for HLA-DR and HLA-DQ with DP0402 (OR = 0.45 [0.38-0.55] p = 8.99 × 10(-17)) and DP0501 (OR = 1.38 [1.18-1.61], p = 7.11 × 10(-5)). HLA-class-II-independent associations with HLA-A(∗)11:01 (OR = 1.32 [1.13-1.54], p = 4.92 × 10(-4)), HLA-B(∗)35:03 (OR = 1.96 [1.41-2.70], p = 5.14 × 10(-5)), and HLA-B(∗)51:01 (OR = 1.49 [1.25-1.78], p = 1.09 × 10(-5)) were also seen across ethnic groups in the HLA class I region. These effects might reflect modulation of autoimmunity or indirect effects of HLA class I and HLA-DP alleles on response to viral infections such as that of influenza.

Indexed as

AllelesAsian PeopleCase-Control StudiesCohort StudiesFemaleGenetic LociHaplotypesHistocompatibility Antigens Class IHLA-B AntigensHLA-DP AntigensHLA-DP beta-ChainsHLA-DQ alpha-ChainsHLA-DR AntigensHumansInfluenza A Virus, H1N1 SubtypeMaleHistocompatibility Antigens Class IHLA-B AntigensHLA-DP AntigensHLA-DPB1 antigenHLA-DP beta-ChainsHLA-DQA1 antigenHLA-DQ alpha-ChainsHLA-DR Antigens

Identifiers

PMID25574827
PMCPMC4289679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.